SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/768BEB624F65D04BDF44A7E81959A7190B7E2D46358F36A3B6CA3FAEC66292FB2034B90DFD9B832050944405FF98ABC3>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/768BEB624F65D04BDF44A7E81959A7190B7E2D46358F36A3B6CA3FAEC66292FB2034B90DFD9B832050944405FF98ABC3
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/768BEB624F65D04BDF44A7E81959A7190B7E2D46358F36A3B6CA3FAEC66292FB2034B90DFD9B832050944405FF98ABC3
http://www.w3.org/2000/01/rdf-schema#comment
"low levels of TUBB3 in serum could predict better response and survival for advanced gastric cancer patients receiving paclitaxel plus capecitabine."
xsd:string
http://purl.uniprot.org/uniprot/#_09673846D35BEF3A13B1FC177D606000C0E942C7680722261DD742B6B200B4B35B36DBC914A19AB73026DF234662C249
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/768BEB624F65D04BDF44A7E81959A7190B7E2D46358F36A3B6CA3FAEC66292FB2034B90DFD9B832050944405FF98ABC3
http://purl.uniprot.org/uniprot/Q3ZCR3
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/768BEB624F65D04BDF44A7E81959A7190B7E2D46358F36A3B6CA3FAEC66292FB2034B90DFD9B832050944405FF98ABC3
http://purl.uniprot.org/uniprot/#_Q3ZCR3-mappedCitation-22766748
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/768BEB624F65D04BDF44A7E81959A7190B7E2D46358F36A3B6CA3FAEC66292FB2034B90DFD9B832050944405FF98ABC3